Cover Feature: Aptamers for SARS-CoV-2: Isolation, Characterization, and Diagnostic and Therapeutic Developments (Anal. Sens. 5/2022)
- PMID: 35936648
- PMCID: PMC9347628
- DOI: 10.1002/anse.202200035
Cover Feature: Aptamers for SARS-CoV-2: Isolation, Characterization, and Diagnostic and Therapeutic Developments (Anal. Sens. 5/2022)
Abstract
The cover feature image shows nucleic acid aptamers armed and ready for our battle against the monstrous SARS-CoV-2 virus. Often thought of as "chemical antibodies", these molecular recognition elements are equipped with several unique benefits and have thus been a popular research subject worldwide. Many aptamers for recognizing the spike and nucleocapsid proteins of SARS-CoV-2 have been developed and examined as diagnostic and therapeutic weaponry for the war against COVID-19 and future pandemics. More information can be found in the Review by J. D. Brennan, Y. Li, and co-workers.
Keywords: COVID-19; aptamers; assays; diagnostics; therapeutics.
© 2022 Wiley‐VCH GmbH.
Similar articles
-
Aptamers for SARS-CoV-2: Isolation, Characterization, and Diagnostic and Therapeutic Developments.Anal Sens. 2022 Sep;2(5):e202200012. doi: 10.1002/anse.202200012. Epub 2022 May 12. Anal Sens. 2022. PMID: 35574520 Free PMC article. Review.
-
Aptamer-engaged nanotherapeutics against SARS-CoV-2.Discov Nano. 2025 Apr 27;20(1):71. doi: 10.1186/s11671-025-04245-3. Discov Nano. 2025. PMID: 40289185 Free PMC article. Review.
-
Aptamers-Diagnostic and Therapeutic Solution in SARS-CoV-2.Int J Mol Sci. 2022 Jan 26;23(3):1412. doi: 10.3390/ijms23031412. Int J Mol Sci. 2022. PMID: 35163338 Free PMC article. Review.
-
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.JCI Insight. 2020 Sep 17;5(18):e142386. doi: 10.1172/jci.insight.142386. JCI Insight. 2020. PMID: 32796155 Free PMC article.
-
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.J Virol. 2022 May 11;96(9):e0038922. doi: 10.1128/jvi.00389-22. Epub 2022 Apr 12. J Virol. 2022. PMID: 35412347 Free PMC article.
Cited by
-
Nucleocapsid protein binding DNA aptamers for detection of SARS-COV-2.Curr Res Biotechnol. 2023;5:100132. doi: 10.1016/j.crbiot.2023.100132. Epub 2023 May 27. Curr Res Biotechnol. 2023. PMID: 37275459 Free PMC article.
References
-
- Anal Sens. 2022 Sep;2(5):e202200035 - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous